tumor cells immunoreactive with a monoclonal antiserum raised against pap in carcinomas of grades ii and iii were less frequent than tumor cells immunoreactive with antisera against psa , beta-msp , and a polyclonal antiserum against pap .
C0525289
beta-msp
C0033572
pap